Perkins Caufield & Byers Xi... Net Worth

The estimated Net Worth of Perkins Caufield & Byers Xi... is at least $203 Milión dollars as of 15 April 2021. Perkins Xi owns over 18,127 units of Progyny Inc stock worth over $201,634,844 and over the last 11 years Perkins sold PGNY stock worth over $912,151.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Perkins Xi PGNY stock SEC Form 4 insiders trading

Perkins has made over 1 trades of the Progyny Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Perkins sold 18,127 units of PGNY stock worth $912,151 on 15 April 2021.

The largest trade Perkins's ever made was selling 18,127 units of Progyny Inc stock on 15 April 2021 worth over $912,151. On average, Perkins trades about 1,648 units every 0 days since 2013. As of 15 April 2021 Perkins still owns at least 8,805,015 units of Progyny Inc stock.

You can see the complete history of Perkins Xi stock trades at the bottom of the page.

What's Perkins Xi's mailing address?

Perkins's mailing address filed with the SEC is 2750 SAND HILL ROAD2750 SAND HILL ROAD, , MENLO PARKMENLO PARK, CACA, 9402594025.

Insiders trading at Progyny Inc

Over the last 5 years, insiders at Progyny Inc have traded over $949,717,514 worth of Progyny Inc stock and bought 76,923 units worth $999,999 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Plc Gsk a Gp A, Llcbonderman Davidcou.... On average, Progyny Inc executives and independent directors trade stock every 4 days with the average trade being worth of $2,005,422. The most recent stock trade was executed by Michael E Sturmer on 16 July 2024, trading 9,030 units of PGNY stock currently worth $270,900.

What does Progyny Inc do?

progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. progyny’s approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. the benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. progyny supports all fertility solutions to include ivf, iui, embryo banking, egg freezing, adoption and surrogacy.

Complete history of Perkins Xi stock trades at Epizyme Inc, Chegg Inc a Progyny Inc

Progyny Inc executives and stock owners

Progyny Inc executives and other stock owners filed with the SEC include:

• David Schlanger,
  Chief Executive Officer, Director
• Peter Anevski,
  President, Chief Operating Officer
• David J. Schlanger,
  Exec. Chairman
• Peter Anevski,
  Chief Exec. Officer
• Mark S. Livingston,
  Chief Financial Officer
• Jennifer Bealer,
  Exec. VP, Gen. Counsel & Sec.
• Jeffrey Park,
  Independent Director
• Cheryl Scott,
  Independent Director
• Kevin Gordon,
  Independent Director
• Beth Seidenberg,
  Independent Chairman of the Board of Directors
• Norman Payson,
  Independent Director
• Frederick Cohen,
  Independent Director
• Roger Holstein,
  Director
• Malissia Clinton,
  Director
• Lisa Greenbaum,
  Executive Vice President, Chief Client Officer
• Jennifer Bealer,
  Executive Vice President, General Counsel
• Mark Livingston,
  Chief Financial Officer, Principal Accounting Officer
• Julie Stadlbauer,
  Exec. VP of Strategic Sales & Partnerships
• Michael Sturmer,
  Pres
• Cassandra Pratt,
  Sr. VP of People
• Risa Fisher,
  Exec. VP of Marketing & Communication
• James Hart,
  VP of Investor Relations
• Fred E Cohen,
  Director
• Xiii Associates, Llc Kpcb,
  10% owner
• Karin Ajmani,
  EVP, Chief of Strategic Dev.
• Perkins Caufield & Byers Xi...,
  
• Plc Gsk,
  10% owner
• Group Holdings (Sbs) Adviso...,
  
• Lloyd H Dean,
  Director
• Gp A, Llcbonderman Davidcou...,
  
• Allison Swartz,
  EVP, GC
• Michael E Sturmer,
  PRESIDENT